Radiaction Medical Unveils Innovative Radiation Protection Solution at RSNA 2021

Demonstrating over 92% protection to the entire medical team during fluoroscopy-based procedures

Radiaction Medical (“Radiaction”), a medical device company, is launching its US operation with a first demonstration of its innovative radiation shielding solution, protecting entire medical teams from scattered radiation in interventional suites.

Radiaction will present at the Radiological Society of North America (“RSNA”) annual conference, at the McCormick Place, Chicago, booth #6949, November 28th through December 2nd, 2021. Visitors are welcome to learn about the technology and its advantages, see a live demonstration and an interactive multimedia presentation.

Radiaction is revolutionizing radiation protection by launching the only solution on the market that provides full-body shielding to all medical personnel during fluoroscopy-guided procedures, without compromising procedural workflow. Real-life clinical experience has demonstrated an entire room scattered radiation reduction performance of 91% in Interventional Cardiology procedures and 93% in Electrophysiology procedures. Specifically, the system nearly eliminates radiation exposure to the head, which is unprotected with commonly used equipment.

Mounted on the C-arm, the system encapsulates the imaging beam and blocks the scattered radiation at its origin. The system retrofits existing fixed C-arms and is intended for use in Interventional Cardiology, Electrophysiology and Interventional Radiology labs, where physicians experience the highest rates of radiation exposure.

“We are very excited to enter the US market,” says Mr. Jonathan Yifat, Radiaction’s CEO. “A demonstration center is being built in Florida which will allow partners and physicians to work with the system and evaluate its seamless integration into the clinical workflow. We are highly encouraged from feedback provided by initial users, pipeline centers and customers and are looking forward to changing the paradigm of protection for the medical team during fluoroscopy-based procedures.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."
Adrian Mendes, Perimeter's Chief Executive Officer, stated, "We believe this additional commercial placement within a major national healthcare system – representing the fifth unit placed with this existing customer network – demonstrates that surgeon end users, as well as other stakeholders within the broader healthcare system, see the value of our technology and are recommending it to their peers. Our aim is to make Perimeter's innovative technology the standard of care in cancer surgery."

By using this website you agree to accept Medical Device News Magazine Privacy Policy